Cite

HARVARD Citation

    Zou, W. et al. (2021). Up-regulation of S100P predicts the poor long-term survival and construction of prognostic signature for survival and immunotherapy in patients with pancreatic cancer. Bioengineered. 12 (1), pp. 9006-9020. [Online]. 
  
Back to record